Infusion Duration for CellCept and Basiliximab in Adult Heart Transplantation
CellCept (mycophenolate mofetil) must be infused intravenously over NO LESS THAN 2 HOURS, and basiliximab is administered as a 20-30 minute intravenous infusion. 1, 2
CellCept (Mycophenolate Mofetil) Infusion Protocol
For adult cardiac transplant patients, the standard dose is 1.5 g administered intravenously every 12 hours (3 g daily total dose). 1
Critical Infusion Requirements:
- Minimum infusion time: 2 hours via peripheral or central vein 1
- Never administer as rapid or bolus IV injection - this is explicitly contraindicated due to safety concerns 1
- Must be reconstituted and diluted to 6 mg/mL concentration using 5% Dextrose Injection USP 1
- Can be administered for up to 14 days post-transplant; patients should transition to oral formulation as soon as they can tolerate oral medication 1
Preparation Details:
The two-step preparation involves:
- Reconstituting 3 vials (for 1.5 g dose) with 14 mL of 5% Dextrose per vial
- Further diluting the reconstituted solution into 210 mL of 5% Dextrose to achieve final 6 mg/mL concentration 1
Basiliximab Infusion Protocol
Basiliximab is administered as 20 mg intravenously over 20-30 minutes. 2
Dosing Schedule:
- First dose: Given within 2 hours before transplant surgery (typically 1 hour pre-operatively) 3
- Second dose: Given 4 days post-transplant 2, 3
Important Timing Considerations:
Research demonstrates that early administration of basiliximab (within 24 hours post-transplant) is associated with significantly better rejection prevention compared to delayed administration (72% vs 29% freedom from acute rejection, p<0.05). 4 This emphasizes the critical importance of adhering to the recommended dosing schedule.
Clinical Context
Both medications are typically part of triple immunosuppressive therapy in cardiac transplantation. The standard regimen includes:
- Basiliximab for induction therapy
- Mycophenolate mofetil (0.5-1.0 g twice daily, transitioned from IV to oral)
- Corticosteroids (methylprednisolone initially, then oral prednisone)
- Calcineurin inhibitor (cyclosporine or tacrolimus, often delayed in patients with renal dysfunction) 3, 4
Common Pitfall:
Do not confuse the 2-hour minimum infusion time for CellCept with the shorter 20-30 minute infusion for basiliximab. The prolonged infusion requirement for CellCept is a safety measure to prevent adverse reactions associated with rapid administration. Administering CellCept too rapidly can result in serious complications. 1